Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy have?
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy has 251 citations in the OpenAlex counts ScholarIQ stores.
When was Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy published?
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy has 2020 year in the ScholarIQ index.
What is the open-access status of Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy?
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy has bronze oa status in the ScholarIQ index.
What is the DOI of Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy?
The DOI for Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy is on the source record.
What is the PMID of Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy?
The PMID for Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy is on the source record.
What is the OpenAlex record for Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy?
The OpenAlex for Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy is on the source record.